Health Technology · Pharmaceuticals: Major · NSE: ACCENTMIC · data 2026-10-09
Accent Microcell Limited
Health check: Strong (8.7/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹649.75
Market cap
₹1,549 cr
P/E
35.1
P/B
5.7
ROE
18.7%
ROCE
22.7%
Debt / equity
0
Dividend yield
0.15%
1-year return
150.0%
52-week high
₹731.7
52-week low
₹253
Operating margin
14.9%
Growth
| Revenue (last 12 months) | ₹349 cr |
| Net profit (last 12 months) | ₹44 cr |
| Sales growth, 3 years (yearly) | 20.9% |
| Profit growth, 3 years (yearly) | 53.1% |
Similar companies
NGL Fine-Chem Ltd. (NGLFINE) · Hester Biosciences Limited (HESTERBIO) · Anlon Healthcare Limited (AHCL) · TTK Healthcare Limited (TTKHLTCARE) · Bharat Parenterals Ltd. (BPLPHARMA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ACCENTMIC in NSE Scanner →